Carecapital Share Discussion Threads

[fenseal3] 20/6/2012 15:20

400k buy yesterday and 265k buys today.....someone nibling ready for the turn!!!!!

[27howard] 19/6/2012 17:34

Do not give up, this went from under 1p to over 4p in a couple of days, the market cap is tiny, you know the score, when it starts to move everybody will pile in and the spike will happen, still hopeful of at least 3 times the current price, still
think long term it could be worth double figures, one decent disposal could start
the share price motoring upwards.

[801710245] 19/6/2012 14:37

Sorry Howard, posted that link here from another PC so I could find it on the work one - like to keep an eye on the DJ live.
Meanwhile, I've sort of given up with CARE. No point in selling at this level, so will just have a peep at the share price now and then incase anything ever happens. Watching the footy tonight ?

[27howard] 19/6/2012 11:14

??? Jenny

Nice 400k buy today, time it had a move upwards

[ursus] 14/6/2012 09:58

Cruel, CrockeryRubble, cruel.

[27howard] 14/6/2012 08:13

Yep 0.98p to buy again.

[moz8] 13/6/2012 20:41

Lol...spot on...

[cockneyrebel] 13/6/2012 20:11

You must be bonkers here - Freddy has sold down from 28% or so to 6% at a huge loss - he's bought a miserly few back - probably in the hope others think he's out to buy a lot and they drive the price up for him to sell his last 6% into.

You may as well follow a blind man in a dark street as follow Freddy imo.

CR

[27howard] 13/6/2012 18:53

Looks like it is 1p or less to buy again, that is very cheap.

[fenseal3] 12/6/2012 11:04

Peeps buying millions before news...good news comes along and no buys, i'm fully loaded here other wise i would buy....no funds either at the mo, still cheap as chips...how odd it would be if we go allday without a trade!!!!

[345654] 12/6/2012 10:52

"fried his brain"

He is getting stock for 0.8p and 0.75p, the rest of us have to pay 1p+, nothing wrong with his brain if you ask me !

[ursus] 12/6/2012 10:49

what are you playing at, fred? when sinclair irradiated yr gonads, some of the gamma particles seem to have travelled up and fried yr investing brain.

[27howard] 12/6/2012 09:30

Not one buy on the news !

[fenseal3] 12/6/2012 09:10

Fantastic news today, they are making great progress...i can see why we have Peter Gyllenhammar buying and Trever Brown buying in the millions.

[27howard] 12/6/2012 07:52

Agreement with Varigen Technologies
Share this article
Print
Alert
TIDMCARE

RNS Number : 1427F

Carecapital Group plc

12 June 2012

12 June 2012

CARECAPITAL GROUP PLC

("CareCapital" or "the Company")

Agreement with Varigen Technologies

Diagnosis and Treatment of Malignant Diseases Based on Genetic Testing, Initially Targeted at Women's Health Care

CareCapital (AIM: CARE) announces that it has signed a mutually exclusive agreement ("the Agreement") with Varigen Technologies ("Varigen") to use Varigen's expertise in the areas of genetic testing and its application to both the diagnosis and development of personalized medical treatments for patients with malignant diseases. Under the Agreement, the specialist services supplied by Varigen will initially be made available at CareCapital's planned medical centre in Folkestone, dedicated exclusively to women's health. Varigen will be entitled to a share, after deduction of all operating costs, of 30% of revenues derived from the provision of the services, with CareCapital retaining the remainder.

Varigen is a company established by Mark Hoser, an expert in the field of genetic and medical diagnostics. Following the award of a PhD from St Thomas' Hospital in haematology and coagulation diagnostics, Mark subsequently held various management positions with large, international pharmaceutical companies before founding GeneForm Technologies in 2003 to exploit his patents in molecular diagnostics and pharmacogenomics. After a successful trade sale of GeneForm Technologies, he has continued his focus on personalized medicine and rapid, next generation diagnostics as well as genotyping technologies for the prediction of drug efficiency in oncology.

Commenting on the Agreement, Mike Sinclair, CareCapital's CEO, said,"The addition of Mark's expertise via this agreement with Varigen Technologies is exactly on strategy for us as we build and grow our specialist cancer services business. The services developed with Varigen will be first available at our dedicated women's health care facility but can then be rolled out more widely."

Mark Hoser of Varigen, added, "The personalisation of diagnosis and treatment are critical steps in the future of medical care and translate to best care and improved quality of life for the patient. Varigen is excited to contribute to CareCapital's endeavour's in making this a reality."

For further information, please visit www.carecapital.co.uk or

[mister md] 11/6/2012 15:10

added 50k shares

[345654] 11/6/2012 14:41

This just might go this afternoon after that rns so long as the mm keep the spread
reasonable.

[345654] 11/6/2012 14:38

The seller he is getting them from is pretty distressed as that match was done
at 0.8p and we have to pay 0.97p or higher, still if he is mopping up a sellers
stock that is good enough for me no matter what the price.

[fenseal3] 11/6/2012 14:34

Big time investors buying, small time investors selling.....simples!!!!!

[27howard] 11/6/2012 12:01

Took a million sale at 0.9p earlier, shame nobody sees the potential here
and the price is a lot cheaper to buy, infact lowest ever currently.

[345654] 11/6/2012 09:42

Check out the sell limits size here

750k at 0.93p, buyer in the market !

[27howard] 10/6/2012 18:29

Maybe people should have shares in both HJFe ?

The growth in Proton treatment should be massive.

About Proton Therapy
Proton therapy is a highly-successful, non-invasive external-beam radiation treatment for cancer patients. Unlike traditional radiation therapy which targets a general area, proton beams enter the body with a low dose of radiation and pinpoint designated areas, with minimal impact to surrounding tissue and organs.

Proton therapy has proven highly effective for a wide range of localized tumors in the eyes, head and neck, lungs, prostate, bladder, spinal cord, and gastro intestines. To date there are more than an estimated 73,000 patients worldwide who have been treated using proton therapy.

It is also often the preferred radiation treatment modality option for pediatric cases, as children are more susceptible to injury from conventional x-ray radiation, as their tissues and organs grow rapidly.

[hjfe] 10/6/2012 18:00

Check out TLY, another Dr Michael Sinclair company. Just appointed Clare Thompson from BUPA to become CEO. TLY has been developing patient decision aids for an NHS pilot, and is expected to be successful in forthcoming tendering to develop shared decision making across the NHS nationally.